Artificial Intelligence Biomarkers Predict Poor Efficacy of Bacillus Calmette-Guérin Rechallenge in Previously Bacillus Calmette-Guérin–Treated Nonmuscle-Invasive Bladder Cancer
Open Access
- 1 July 2025
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 214 (1) , 90-91
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Real-World Treatment Patterns and Outcomes in Patients With Bacillus Calmette-Guérin–Unresponsive High-Risk Non–Muscle-Invasive Bladder Cancer: A Multicountry Medical Chart ReviewClinical Genitourinary Cancer, 2025
- Predicting Response to Intravesical BCG in High-Risk NMIBC Using an Artificial Intelligence–Powered Pathology Assay: Development and Validation in an International 12-Center CohortJournal of Urology, 2024
- Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 AmendmentJournal of Urology, 2024
- Treatment patterns and prognosis in patients with Bacillus Calmette–Guérin-exposed high-risk non-muscle invasive bladder cancer: a real-world data analysisWorld Journal of Urology, 2024
- Contemporary oncologic outcomes of second induction course BCG in patients with nonmuscle invasive bladder cancerUrologic Oncology: Seminars and Original Investigations, 2020